Shanghai Baolijia Chemical Co., Ltd. (SHE:301037)
China · Delayed Price · Currency is CNY 16.68
-0.12 (-0.71%)
Feb 26, 2026, 4:00 PM EST
SHE:301037 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Operating Revenue | 1,840 | 2,151 | 2,269 | 2,988 | 2,965 | 2,022 |
Other Revenue | - | - | - | 175.12 | 9.79 | 0.46 |
| 1,840 | 2,151 | 2,269 | 3,163 | 2,975 | 2,022 | |
Revenue Growth (YoY) | -15.12% | -5.23% | -28.25% | 6.32% | 47.11% | -1.57% |
Cost of Revenue | 1,614 | 1,940 | 1,977 | 2,832 | 2,615 | 1,656 |
Gross Profit | 226.04 | 210.41 | 292.28 | 330.93 | 359.45 | 366.26 |
Selling, General & Admin | 197.91 | 222.2 | 232.17 | 223.44 | 199.63 | 182.62 |
Research & Development | 27.42 | 44.99 | 70.03 | 51.28 | 51.9 | 35 |
Other Operating Expenses | 9.42 | 4.4 | 6.17 | 10.29 | 7.44 | 7.01 |
Operating Expenses | 235.26 | 276.23 | 305.78 | 290.51 | 264.54 | 227.54 |
Operating Income | -9.22 | -65.82 | -13.5 | 40.42 | 94.91 | 138.72 |
Interest Expense | -40.15 | -38.6 | -34.6 | -41.74 | -37.84 | -34.49 |
Interest & Investment Income | 9.89 | 1.51 | 1.48 | 2.09 | 2.9 | 1.67 |
Other Non Operating Income (Expenses) | -10.99 | -13.09 | 0.19 | -0.98 | -2.47 | -3.2 |
EBT Excluding Unusual Items | -50.46 | -116 | -46.43 | -0.21 | 57.51 | 102.69 |
Gain (Loss) on Sale of Investments | 0.33 | -0.14 | -2.05 | -7.21 | - | - |
Gain (Loss) on Sale of Assets | 0.01 | 0.56 | 0.02 | 0.1 | 0.02 | - |
Asset Writedown | -13.47 | -15.09 | -0.55 | -0.53 | -0.03 | -0.37 |
Other Unusual Items | -3.95 | -3.95 | 7.04 | 10.59 | -0.57 | 7.85 |
Pretax Income | -67.54 | -134.63 | -41.98 | 2.75 | 56.93 | 110.17 |
Income Tax Expense | 6.22 | 15.32 | -10.48 | -2.99 | 6.48 | 20.37 |
Earnings From Continuing Operations | -73.76 | -149.96 | -31.5 | 5.74 | 50.45 | 89.8 |
Minority Interest in Earnings | 0.56 | 0.29 | 0.21 | - | - | - |
Net Income | -73.19 | -149.67 | -31.3 | 5.74 | 50.45 | 89.8 |
Net Income to Common | -73.19 | -149.67 | -31.3 | 5.74 | 50.45 | 89.8 |
Net Income Growth | - | - | - | -88.63% | -43.82% | 24.89% |
Shares Outstanding (Basic) | 139 | 139 | 141 | 140 | 119 | 104 |
Shares Outstanding (Diluted) | 139 | 139 | 141 | 140 | 119 | 104 |
Shares Change (YoY) | -0.97% | -1.08% | 0.32% | 18.33% | 14.00% | -0.46% |
EPS (Basic) | -0.53 | -1.08 | -0.22 | 0.04 | 0.43 | 0.86 |
EPS (Diluted) | -0.53 | -1.08 | -0.22 | 0.04 | 0.43 | 0.86 |
EPS Growth | - | - | - | -90.39% | -50.72% | 25.47% |
Free Cash Flow | 44.81 | -309.43 | 37.77 | -199.12 | -263.86 | 22.59 |
Free Cash Flow Per Share | 0.32 | -2.22 | 0.27 | -1.42 | -2.23 | 0.22 |
Dividend Per Share | - | - | - | - | 0.039 | - |
Gross Margin | 12.28% | 9.78% | 12.88% | 10.46% | 12.08% | 18.11% |
Operating Margin | -0.50% | -3.06% | -0.60% | 1.28% | 3.19% | 6.86% |
Profit Margin | -3.98% | -6.96% | -1.38% | 0.18% | 1.70% | 4.44% |
Free Cash Flow Margin | 2.44% | -14.39% | 1.66% | -6.30% | -8.87% | 1.12% |
EBITDA | 72.3 | 3.12 | 38.68 | 82.25 | 135.44 | 179.95 |
EBITDA Margin | 3.93% | 0.14% | 1.70% | 2.60% | 4.55% | 8.90% |
D&A For EBITDA | 81.52 | 68.94 | 52.17 | 41.83 | 40.53 | 41.23 |
EBIT | -9.22 | -65.82 | -13.5 | 40.42 | 94.91 | 138.72 |
EBIT Margin | -0.50% | -3.06% | -0.60% | 1.28% | 3.19% | 6.86% |
Effective Tax Rate | - | - | - | - | 11.38% | 18.49% |
Revenue as Reported | 1,840 | 2,151 | 2,269 | 3,163 | 2,975 | 2,022 |
Advertising Expenses | - | 4.27 | 1.6 | 0.86 | 0.31 | 0.84 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.